As the industry has been left scrambling to ensure continuity and minimize disruptions during the pandemic, a greater focus on visibility, transparency, and agility is becoming the new normal.
The COVID-19 pandemic has stressed the global pharmaceutical supply chain in unimaginable ways. As the industry has been left scrambling to ensure continuity and minimize disruptions, a greater focus on visibility, transparency, and agility is becoming the new normal.
Drawing from an actual example demonstrating how real-time monitoring has helped Ipsos MORI, a global market research firm, track location and quality conditions of tens of thousands COVID-19 test kits throughout the UK, attendees will take away a better understanding of and actionable insights into:
Kelly Beaver, Managing Director, Ipsos MORI
Ada Palmadottir, MPharm, MBA, Director of Pharmaceutical Validation and Compliance, Controlant
Erlingur Brynjulfsson, Co-Founder and CTO at Controlant, gives his perspective on integrating data and information from multiple sources into one control tower.
Leveraging the Real-Time Pharma Supply Chain Control Tower